leadf
logo-loader
viewMotif Bio PLC

Motif Bio chief talks up potential US listing

Motif Bio (LON:MTFB) said a listing on the US tech market NASDAQ is very much an option as it brought on board an American investment bank.

MTS Health Partners will advise on its future financing options within the US market, investors were told.

Chief executive Graham Lumsden told Proactive: “One of the differences between the London markets and the US is that there are a large number of specialist pharma-biotech investors in the US.”

What MTS is helping the firm to do, he said, is understand “how we identify the right investors in the US, what our story needs to be, and how we communicate with these people.”

Quick facts: Motif Bio PLC

Price: 0.5 GBX

AIM:MTFB
Market: AIM
Market Cap: £3.27 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Cabral Gold adds 2nd drill rig as company identifies new high-grade veins

Cabral Gold (CVE: CBR-OTC: CBGZF) CEO Alan Carter joined Steve Darling from Proactive Vancouver with news the company has identified at least six new NE trending high-grade veins in the Machichie SW area located immediately north of the MG deposit. Carter telling Proactive what had led them...

2 days, 7 hours ago

2 min read